Intravitreal triamcinolone acetonide injections in treatment of cystoid macular edema due to diabetic maculopathy;Zastosowanie iniekcji octanu triamcinolonu w leczeniu torbielowatego obrzeku plamki w przebiegu makulopatii cukrzycowej

Klinika Oczna

Volumn 109, Issue 4-6, 2007, Pages 165-168

  Lubczyńska, Anna ^a,b   Kociecki, Jarosław ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NONE   (Poland)

Author keywords

Cystoid macula edema; Diabetic maculopathy; Triamcinolone acetonide

Indexed keywords

EID: 34447542392     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photography. ETDRS report number 10. Ophthalmology 1991, 98(5 suppl), 786-806.
2. Krepler K, Wagner J, Scu S, Wedrich A: The effect of intravitreal triamcinolone on diabetic macular oedema. Graef's Arch Clin Exp Ophthalmol 2005, 243, 478-481.
3. Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design an baseline patient characteristic. ETDRS report number 7. Ophthalmology 1001, 98(5 suppl), 741-756.
4. Machamer R, Sugta G, Tano Y: Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979, 77, 171-180.
5. Tano Y, Chandler D, Machemer R: Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980, 90, 810-816.
6. Maritidis A, Duker JS, Greenberg PB, Rogers AH, Puliafatio CA, Reichel E, Baurnal C: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002, 109, 920-927.
7. Jonas JB, Akkoyun I, Kressig I, Degenring RF: Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comperative, non-randomised study. Br J Ophthalmol 2005, 89, 321-326.
8. Jonas JB, Degenring R: Intravitreale Injektion von kristallinem Triamcinolon Acetonid als Therapie des diffusen diabetischen Makulaödems. Klin Monatsbl Augenheilkd 2002, 219, 429-432.
9. Jonas JB, Harder B, Kamppeter BA: Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 2004, 138, 970-977.
10. Kressig I. Degenring RF, Jonas JB: Intravitreales Triamcinolonacetonid Komplikationen von infektiöser und steriler Endophthalmitis. Ophthalmologe 2006, 103(3), 30-34.
11. Jonas JB, Kressig I, Degenring R: Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Progress in retinal and eye Research 2005, 24, 587-611.
12. Larsson J, Zhu M, Sutler F, Gillies MC: Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolne. Am J Ophthalmol 2005, 139, 802-806.
13. Goebel W, Krezchmar-Gross T: Retinal thickness in diabetic retinopathy. Retina 2002, 22, 759-767.
14. Islam MS, Negi A, Veron S.A.: Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular oedema. Eye 2005, 19, 1325-1327.